• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Shockwave Medical Inc (NQ: SWAV )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, May 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Shockwave Medical Inc

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2021
    Upgrades According to Macquarie, the prior rating for 2U Inc (NASDAQ: 
    Via Benzinga
    ShockWave Medical Insights: Return On Capital Employed
    During Q1, ShockWave Medical's (NASDAQ:SWAV) reported sales totaled $31.90 million. Despite a 10.22% in earnings, the company posted a loss of $17.49 million. In Q4, ShockWave... 
    Via Benzinga
    The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
    Via Benzinga
    Exposures COVID-19
    Stocks That Hit 52-Week Highs On Tuesday
    Tuesday's morning session saw 173 companies set new 52-week highs. Significant Points: The largest company by market cap to hit a new 52-week high was JPMorgan... 
    Via Benzinga
    The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
    Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
    Via Benzinga
    Exposures Product Safety
    3 Ridiculously Overpriced Stocks That Could Crash in a Market Correction
    Now may be the time to sell these stocks before their bubbles pop. 
    Via The Motley Fool
    SVB Leerink Believes ShockWave Is Well-Positioned In Calcified Cardiovascular Market
    SVB Leerink has initiated the coverage of ShockWave Medical Inc (NASDAQ: SWAV) with an Outperform rating and a $208 price target, implying an upside of... 
    Via Benzinga
    What 9 Analyst Ratings Have To Say About ShockWave Medical
    ShockWave Medical (NASDAQ:SWAV) has observed the followin... 
    Via Benzinga
    The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ... 
    Via Benzinga
    Stocks That Hit 52-Week Highs On Tuesday
    Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs. Significant Points: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ... 
    Via Benzinga
    Stocks That Hit 52-Week Highs On Tuesday
    Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was... 
    Via Benzinga
    Where ShockWave Medical Stands With Analysts
    ShockWave Medical (NASDAQ:SWAV) has observed the following... 
    Via Benzinga
    The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ... 
    Via Benzinga
    Exposures COVID-19
    Looking Into ShockWave Medical's Return On Capital Employed
    In Q1, ShockWave Medical (NASDAQ:SWAV) posted sales of $31.90 million. Earnings were up 10.22%, but ShockWave Medical still reported an overall loss of $17.49 million. In Q4,... 
    Via Benzinga
    Analyst Ratings for ShockWave Medical
    ShockWave Medical (NASDAQ:SWAV) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 2 0 1... 
    Via Benzinga
    Stocks That Hit 52-Week Highs On Thursday
    Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs. Noteworthy Highlights: The largest company by market cap to hit a new 52-week high was Microsoft... 
    Via Benzinga
    The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:... 
    Via Benzinga
    The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
    Via Benzinga
    Stocks That Hit 52-Week Highs On Monday
    This morning 128 companies set new 52-week highs. Points of Interest: Novo Nordisk (NYSE:NVO) was the biggest firm by market cap to hit a new 52-week high. Taylor... 
    Via Benzinga
    The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
    Via Benzinga
    Stocks That Hit 52-Week Highs On Friday
    Friday's morning session saw 160 companies set new 52-week highs. Areas of Significance: The largest company by market cap to set a new 52-week high was AbbVie... 
    Via Benzinga
    Stocks That Hit 52-Week Highs On Monday
    During Monday's morning session, 255 companies made new 52-week highs. Points of Interest: The largest company by market cap to set a new 52-week high was Adobe (... 
    Via Benzinga
    Stocks That Hit 52-Week Highs On Friday
    Before 10 a.m. ET Friday, 188 stocks made new 52-week highs. Things to Consider: The largest company by market cap to set a new 52-week high was Coca-Cola (NYSE:KO... 
    Via Benzinga
    The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc... 
    Via Benzinga
    The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company... 
    Via Benzinga
    Stock Market Rally Struggles With Inflation Spike; Tesla Sales Fall, Elon Musk Turns On Bitcoin As Coinbase Reports
    The market rally tested key levels as inflation fears mounted. Tesla's China sales dived as CEO Elon Musk dissed Bitcoin. 
    Via Investor's Business Daily
    56 Biggest Movers From Yesterday
    Gainers Bridgford Foods Corporation (NASDAQ: BRID) shares surged 46.2% to close at $20.74 on Tuesday. Sequential Brands Group, Inc. (NASDAQ: SQBG) shares jumped 36.5% to close at... 
    Via Benzinga
    Why Shockwave Medical Stock Jumped Today
    The health tech specialist could save lives -- and deliver impressive growth to shareholders along the way. 
    Via The Motley Fool
    Shockwave Medical Stock Jumps On Q1 Revenue Growth, Analyst Upgrades
    Shockwave Medical Inc (NSDQ: SWAV) first-quarter FY21 sales more than double to $31.9 million beating the Wall Street consensus of $29.9 million. The growth was... 
    Via Benzinga
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.